Skip to content

IceCure Medical

Recent events

Recent events tied to this brand in public sources.

Back to profile8 entries

  1. 2021

    IceCure receives notice of intention to grant European patent

    IceCure Medical announced that the European Patent Office notified it of an intention to grant a patent for its “Cryogen Pump” application. The patent had not yet been issued.

  2. 2021

    IceCure Medical prices $15 million public offering

    IceCure Medical announced pricing for an underwritten public offering of ordinary shares and pre-funded warrants. The company said gross proceeds were expected to be approximately $15 million, before offering expenses; closing was expected on or about December 13, 2021.

  3. 2021

    IceCure expands ProSense distribution network

    IceCure reported expanding the ProSense distribution network, adding exclusive sales arrangements in Turkey and Brazil, a distributor in parts of India, and Thailand to its distribution partnership with Terumo, which already covered Japan and Singapore.

  4. 2021

    IceCure reports first-half 2021 financial results

    IceCure Medical reported its financial results for the six-month period ended June 30, 2021. It reported revenue of approximately $2.1 million and a net loss of approximately $3.8 million for the period.

  5. 2021

    IceCure announces exclusive distribution agreement with Rise General Trading

    IceCure announced an exclusive distribution agreement with Rise General Trading for the ProSense Cryoablation System in the United Arab Emirates and Arabian Gulf States. The agreement is for three years.

  6. 2020

    IceCure and Terumo announce expanded distribution partnership in Thailand

    IceCure Medical announced an expanded partnership with Terumo under which Terumo is expected to receive exclusive rights to distribute IceCure products in Thailand for six years; the agreement was expected to be finalized by year-end.

  7. 2020

    IceCure signs exclusive German distribution agreement with MTS Medical Technology

    IceCure Medical entered into an exclusive distribution agreement with MTS Medical Technology to commercialize its ProSense cryoablation system and consumables in Germany. The agreement calls for MTS Medical to purchase a minimum of EUR 375,000 in products and consumables by the end of March 2021.

  8. 2019

    IceCure Medical appoints Sharon Levita to its board

    IceCure Medical announced the appointment of Sharon Levita to its board of directors, increasing the board to six members.